Official reprint from UpToDate®
www.uptodate.com ©2018 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Endometrial ablation: Non-resectoscopic techniques

Howard T Sharp, MD
Section Editor
Tommaso Falcone, MD, FRCSC, FACOG
Deputy Editor
Sandy J Falk, MD, FACOG


The introduction of non-resectoscopic ablation techniques has greatly increased the use of endometrial ablation as a therapeutic option for women with abnormal uterine bleeding. Non-resectoscopic endometrial ablation is performed with a device that is inserted into the uterine cavity and delivers energy to uniformly destroy the uterine lining. Non-resectoscopic techniques are also referred to as second generation ablation.

Resectoscopic endometrial ablation techniques, on the other hand, are performed under hysteroscopic visualization, using resectoscopic instruments to ablate or resect the endometrium. Non-resectoscopic endometrial ablation techniques are more widely practiced than resectoscopic ablation, since they require less specialized training and have a shorter operative time [1].

Non-resectoscopic techniques for endometrial ablation will be reviewed here. General principles (eg, indications, contraindications, preoperative and postoperative care) of endometrial ablation, techniques for resectoscopic endometrial ablation or resection, as well as other management options for abnormal uterine bleeding, are discussed separately. (See "An overview of endometrial ablation" and "Endometrial ablation or resection: Resectoscopic techniques" and "Management of abnormal uterine bleeding".)


Current non-resectoscopic endometrial ablation technologies approved for use in the United States by the Food and Drug Administration (FDA) are:

Bipolar radiofrequency (NovaSure)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Dec 2017. | This topic last updated: Jun 01, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2018 UpToDate, Inc.
  1. Deb S, Flora K, Atiomo W. A survey of preferences and practices of endometrial ablation/resection for menorrhagia in the United Kingdom. Fertil Steril 2008; 90:1812.
  2. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p020031 (Accessed on February 16, 2010).
  3. McCausland AM, McCausland VM. Partial rollerball endometrial ablation: a modification of total ablation to treat menorrhagia without causing complications from intrauterine adhesions. Am J Obstet Gynecol 1999; 180:1512.
  4. Bae IH, Pagedas AC. Comparison of Partial and Complete Endomyometrial Resection with Rollerball Endometrial Ablation. J Am Assoc Gynecol Laparosc 1996; 3:S2.
  5. www.novasure.com/novasure-procedure/novasure-instructions.cfm (Accessed on February 24, 2010).
  6. Shazly SA, Famuyide AO, El-Nashar SA, et al. Intraoperative Predictors of Long-term Outcomes After Radiofrequency Endometrial Ablation. J Minim Invasive Gynecol 2016; 23:582.
  7. Fulop T, Rákóczi I, Barna I. NovaSure impedance controlled endometrial ablation: long-term follow-up results. J Minim Invasive Gynecol 2007; 14:85.
  8. Gallinat A. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients. J Reprod Med 2007; 52:467.
  9. Sabbah R, Desaulniers G. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J Minim Invasive Gynecol 2006; 13:467.
  10. Cooper KG, Bain C, Parkin DE. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial. Lancet 1999; 354:1859.
  11. Sambrook AM, Bain C, Parkin DE, Cooper KG. A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium: follow up at a minimum of 10 years. BJOG 2009; 116:1033.
  12. http://www.accessdata.fda.gov/cdrh_docs/pdf2/P020031b.pdf (Accessed on May 26, 2010).
  13. www.ethicon360.com/products/gynecare-thermachoice-uterine-balloon-therapy-system (Accessed on February 24, 2010).
  14. http://www.pnnmedical.com/?tabid=75 (Accessed on February 24, 2010).
  15. http://www.thermablate-eas.com/thermablate/AboutThermablate/ForMedical/ForMedicalPage1.aspx (Accessed on February 24, 2010).
  16. Amso NN, Fernandez H, Vilos G, et al. Uterine endometrial thermal balloon therapy for the treatment of menorrhagia: long-term multicentre follow-up study. Hum Reprod 2003; 18:1082.
  17. Ahonkallio S, Martikainen H, Santala M. Endometrial thermal balloon ablation has a beneficial long-term effect on menorrhagia. Acta Obstet Gynecol Scand 2008; 87:107.
  18. Mettler L. Long-term results in the treatment of menorrhagia and hypermenorrhea with a thermal balloon endometrial ablation technique. JSLS 2002; 6:305.
  19. Chapa HO, Venegas G, Antonetti AG, et al. In-office endometrial ablation using a third-generation uterine balloon therapy system: 12-month prospective follow-up on menstrual patterns and dysmenorrhea impact. J Reprod Med 2009; 54:678.
  20. El-Toukhy T, Chandakas S, Grigoriadis T, et al. Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm plus. J Obstet Gynaecol 2004; 24:680.
  21. Karamanidis D, Nicolaou P, Byros A, Koutsougeras G. Two-year results of a new two-minute hot liquid balloon endometrial ablation system (Thermablate): a pilot study. Clin Exp Obstet Gynecol 2009; 36:256.
  22. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol 2007; 109:1233.
  23. Soysal ME, Soysal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gynecol Obstet Invest 2001; 51:128.
  24. Thamban S, Garg S, Al-Habib A, El-Farra KE. Thermal balloon endometrial ablation in bicornuate uteri. J Obstet Gynaecol 2007; 27:324.
  25. Townsend DE, Duleba AJ, Wilkes MM. Durability of treatment effects after endometrial cryoablation versus rollerball electroablation for abnormal uterine bleeding: two-year results of a multicenter randomized trial. Am J Obstet Gynecol 2003; 188:699.
  26. Duleba AJ, Heppard MC, Soderstrom RM, Townsend DE. A randomized study comparing endometrial cryoablation and rollerball electroablation for treatment of dysfunctional uterine bleeding. J Am Assoc Gynecol Laparosc 2003; 10:17.
  27. (Accessed on February 25, 2010).
  28. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2005; :CD001501.
  29. Goldrath MH. Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 Years after treatment. J Am Assoc Gynecol Laparosc 2003; 10:505.
  30. Ammar K, Koukoura O. Management of menorrhagia with hydrothermal endometrial ablation in 2 women with bicornuate uteri. J Minim Invasive Gynecol 2009; 16:795.
  31. whttp://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM (Accessed on April 21, 2009).
  32. Gurtcheff SE, Sharp HT. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 2003; 102:1278.
  33. Della Badia C, Nyirjesy P, Atogho A. Endometrial ablation devices: review of a manufacturer and user facility device experience database. J Minim Invasive Gynecol 2007; 14:436.
  34. Milingos S, Protopapas A, Papadimitriou C, et al. Laparoscopy in the evaluation of women with unexplained ascites: an invaluable diagnostic tool. J Minim Invasive Gynecol 2007; 14:43.
  35. https://google2.fda.gov/search?as_sitesearch=https://www.accessdata.fda.gov/cdrh_docs/pdf14&q=minerva&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&requiredfields=-archive:Yes&output=xml_no_dtd&getfields=*&ie=UTF-8&ulang=en&&access=p&sort=date:D:L:d1&entqr=1&entqrm=0&wc=200&wc_mc=1&oe=UTF-8&u (Accessed on May 15, 2017).
  36. Laberge P, Garza-Leal J, Fortin C, et al. One-Year Follow-Up Results of a Multicenter, Single-Arm, Objective Performance Criteria-Controlled International Clinical Study of the Safety and Efficacy of the Minerva Endometrial Ablation System. J Minim Invasive Gynecol 2015; 22:1169.
  37. Laberge P, Garza-Leal J, Fortin C, et al. A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results. J Minim Invasive Gynecol 2017; 24:124.
  38. Bongers MY, Bourdrez P, Mol BW, et al. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG 2004; 111:1095.
  39. Kleijn JH, Engels R, Bourdrez P, et al. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG 2008; 115:193.
  40. Abbott J, Hawe J, Hunter D, Garry R. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003; 80:203.
  41. Sambrook AM, Cooper KG, Campbell MK, Cook JA. Clinical outcomes from a randomised comparison of Microwave Endometrial Ablation with Thermal Balloon endometrial ablation for the treatment of heavy menstrual bleeding. BJOG 2009; 116:1038.
  42. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97:734.
  43. Penninx JP, Mol BW, Engels R, et al. Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol 2010; 116:819.
  44. Herman MC, Penninx JP, Mol BW, Bongers MY. Ten-year follow-up of a randomised controlled trial comparing bipolar endometrial ablation with balloon ablation for heavy menstrual bleeding. BJOG 2013; 120:966.
  45. Hachmann-Nielsen E, Rudnicki M. Clinical outcome after hydrothermal ablation treatment of menorrhagia in patients with and without submucous myomas. J Minim Invasive Gynecol 2012; 19:212.
  46. AlHilli MM, Hopkins MR, Famuyide AO. Endometrial cancer after endometrial ablation: systematic review of medical literature. J Minim Invasive Gynecol 2011; 18:393.
  47. Clark TJ, Samuel N, Malick S, et al. Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial. Obstet Gynecol 2011; 117:109.